drugset / Trial / NCT01452776

Long-Term Safety Study of TAK-438 in the Maintenance Treatment of Healed Erosive Esophagitis

NCT01452776

Phase 3 Completed 305 enrolled Takeda
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to determine the safety of long term use of TAK-438, once daily (QD), for the maintenance treatment of healed erosive esophagitis.

Timeline

Start
2011-09
Primary completion
2013-07
Completion
2013-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Vonoprazan Other / unclassified 10 mg Oral
Subject Vonoprazan Other / unclassified 20 mg Oral

Indications